Lei Zhang | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Prof. Lei Zhang | Clinical Neuroscience | Research Excellence Award

Prof. Lei Zhang | The First Affiliated Hospital of Wenzhou Medical University | China

Lei Zhang is a male Chinese orthopaedic surgeon and scientist, currently serving as Professor, Chief Director, and Master Supervisor in the Department of Orthopaedics at The First Affiliated Hospital of Wenzhou Medical University. He holds both M.D. and Ph.D. degrees from the School of Medicine, Zhejiang University, and specializes clinically in arthroplasty and sports medicine, with a scientific focus on tissue engineering for bone and cartilage repair. His international training includes fellowships at Graz University, Singapore General Hospital, WaldKrankenhaus Hospital in Bonn, Peking University Third Hospital, JST Hospital, and Ewha Womans University Seoul Hospital, reflecting broad exposure to advanced orthopaedic techniques and translational research. Professor Zhang is actively engaged in professional service, holding leadership and membership roles in multiple branches of the Zhejiang Medical Association and related orthopedic, sports medicine, and tissue repair societies. He also contributes to academic publishing as Chief Editor of special issues in Frontiers in Bioengineering and Biotechnology and as Associate Editor for the Injury Prevention and Rehabilitation specialty in Frontiers in Sports and Active Living. His scholarly output includes 89 published documents, with 4,362 total citations from 4,083 citing documents and an h-index of 28, demonstrating sustained impact in orthopaedics, sports medicine, and regenerative tissue engineering.

Citation Metrics (Scopus)

8000
6000
4000
2000
0

Citations
4362

Documents
89

h-index
28

Citations

Documents

h-index


View Scopus Profile
 View Google Scholar Profile
 View Orcid Profile

Featured Publications

Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Fiona Stanley | Australia

Dr. Hendry Ramly is a clinician–researcher with advanced training in general medicine, cardiology, and intensive care medicine, and a focused academic interest in non-traumatic out-of-hospital cardiac arrest and post-resuscitation care. His research is directly informed by frontline clinical practice across acute medicine, ICU, and cardiology, where he manages critically ill patients following cardiac arrest. Dr. Ramly’s primary research examines cardiovascular management strategies after return of spontaneous circulation, with particular emphasis on haemodynamic stabilisation, coronary pathology, and the timing and utility of urgent coronary angiography. Neurological outcomes are included as standard clinical endpoints, while the central focus remains on cardiovascular determinants of survival and in-hospital mortality. He is lead author of a retrospective observational cohort study published in Heart, Lung and Circulation (2025), evaluating outcomes of non-traumatic out-of-hospital cardiac arrest at a tertiary centre. His additional audit work includes thoracic surgical outcomes, geriatric referral pathways, and procedural adequacy in respiratory medicine. Through clinically driven research and multidisciplinary collaboration, Dr. Ramly aims to refine evidence-based pathways that improve survival, decision-making, and quality of care for patients following cardiac arrest.


View ORCID Profile

Featured Publication

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Maria -Camelia Stancioaica | Clinical Neuroscience |

Published on by Neuroscientists

Ms. Maria -Camelia Stancioaica | Clinical Neuroscience | Best Researcher Award

Ms. Maria -Camelia Stancioaica | Fundeni Clinical Hospital | Romania

Dr. Maria Camelia Stăncioaica is a dedicated Romanian hematologist affiliated with the Fundeni Clinical Institute in Bucharest, where she serves as the Acute Leukemia Program Coordinator. She holds an M.D. in Clinical Hematology and is currently pursuing her Ph.D. at the Carol Davila University of Medicine. Her professional development includes international experience through observership at Johns Hopkins Hospital in the USA and an internship at Pitié–Salpêtrière Hospital in France. Dr. Stăncioaica has contributed to advancing hematologic research through publications addressing acute leukemia, fungal infections in immunocompromised patients, and targeted therapies in acute myeloid leukemia. Her notable works include studies on FLT3 inhibitors, differentiation syndrome in pregnancy, and invasive fusariosis outbreaks. Actively engaged in global scientific dialogue, she has been a speaker and session chair at prominent hematology conferences across Europe. She also participates in several clinical trials as both principal and subinvestigator, focusing on novel therapeutic strategies in leukemia management. Dr. Stăncioaica’s research achievements are reflected in her 21 citations, 2 h-index, and 1 i10-index, underscoring her growing influence in clinical hematology. She is a member of the European Hematology Association and the Romanian Society of Hematology, contributing to both national and international medical communities.

Profile: Google Scholar

Featured Publications

1. Ghiaur, A., Doran, C., Gaman, M. A., Ionescu, B., Tatic, A., Cirstea, M., … Stancioaica, M. C. (2024). Acute promyelocytic leukemia: Review of complications related to all-trans retinoic acid and arsenic trioxide therapy. Cancers, 16(6), 1160.

2. Mohorea‐Neata, A. L., Ghita, M. C., Moroti, R., Ghiaur, A., Ionescu, B., Tatic, A., … Stancioaica, M. C. (2023). Invasive fusariosis in acute leukaemia patients—An outbreak in the haematology ward. Mycoses, 66(8), 705–710.

3. Droc, G., Stancioaica, M. C., Soare, C. G., Stefan, M. G., Ingustu, D., Martac, C., … Ghiaur, A. (2023). Acute promyelocytic leukemia and severe differentiation syndrome in pregnancy—A management challenge. Life, 13(5), 1141.

4. Coriu, D., & Stancioaica, M. C. (2023). Moving low-risk myelodysplastic syndromes from humans to mice: Is it truly that simple? Haematologica, 109(1), 8.

5. Stancioaica, M. C., Coriu, D., & Ghiaur, G. (2025). FLT3: A 35-year voyage from discovery to the next generation of targeted therapy in AML. Cancers.

Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Published on by Neuroscientists

Assist. Prof. Dr. Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Assist. Prof. Dr. Chun-An Cheng | Tri-Service General Hospital | Taiwan

Assistant Professor Dr. Chun-An Cheng is a distinguished researcher affiliated with the Tri-Service General Hospital, Taiwan, known for his significant contributions to medical and clinical research. He has authored 73 scholarly documents, which have collectively garnered 658 citations across 620 publications, reflecting the wide impact and recognition of his scientific work. With an h-index of 14, Dr. Cheng has demonstrated consistent research productivity and influence within his field. His research encompasses multidisciplinary areas in clinical medicine, focusing on advancing diagnostic methodologies, therapeutic innovations, and patient-centered healthcare strategies. Through his collaborations and publications, Dr. Cheng has contributed to improving the understanding of complex medical conditions and enhancing evidence-based clinical practices. His dedication to translational research bridges the gap between laboratory findings and clinical applications, reinforcing his role as a key figure in the Taiwanese medical research community. Dr. Cheng continues to drive impactful studies that promote innovation, patient safety, and improved health outcomes, positioning him as a leading voice in contemporary clinical science.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • (2025). Effects of exposure to air pollution and cold weather on acute myocardial infarction mortality. Atmosphere.

  • (2025). The risk of ischemic stroke in patients with chronic obstructive pulmonary disease and atrial fibrillation. Life.

  •  (2024). Increased risk of psychiatric disorder in patients with hearing loss: A nationwide population-based cohort study. Journal of Translational Medicine.

  • (2024). Diabetes mellitus and gynecological and inflammation disorders increased the risk of pregnancy loss in a population study. Life.

  • (2024). The influence of fine particulate matter and cold weather on emergency room interventions for childhood asthma. Life.

  • (2024). Impact of foodborne disease in Taiwan during the COVID-19 pandemic. Medicina (Lithuania).

  • (2024). Analyzing COVID-19 and air pollution effects on pediatric asthma emergency room visits in Taiwan. Toxics.

Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | University of Tokyo | Japan

Dr. Tatsuya Yamasoba is a Professor Emeritus at the University of Tokyo and Director of Tokyo Teishin Hospital, recognized internationally for his contributions to otology, neurotology, laryngology, and clinical neuroscience. He has published over 500 scientific papers in leading journals such as Science, Nature Chemistry, Nature Nanotechnology, Neuron, PNAS, and Neurology. His research focuses on regenerative medicine for sensorineural hearing loss, vestibular dysfunction, and dysphagia management in neurodegenerative diseases. With a citation index of over 24,150, an h-index of 75, and an i10-index of 353, his work has significantly advanced understanding and treatment of auditory and balance disorders. He has developed surgical techniques for severe hearing loss, pioneered galvanic vestibular stimulation therapy for disequilibrium, and improved aspiration prevention surgeries. Dr. Yamasoba has served as Editor-in-Chief of Auris Nasus Larynx and Associate Editor for ORL Journal and npj Aging and Mechanisms of Disease. He collaborates with leading research institutions including the University of Michigan and the University of California, Davis. His professional memberships include the International Federation of ORL Societies and the Asia Oceania Otorhinolaryngology and Head and Neck Society, reflecting his leadership and influence in advancing otolaryngology and auditory neuroscience globally.

Profile: Google Scholar

Featured Publications

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., et al. (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309(5733), 481–484.

Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., et al. (2015). Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC study. Allergy, 70(8), 995–1003.

Yamasoba, T., Lin, F. R., Someya, S., Kashio, A., Sakamoto, T., & Kondo, K. (2013). Current concepts in age-related hearing loss: Epidemiology and mechanistic pathways. Hearing Research, 303, 30–38.

Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., & Miller, J. M. (2007). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.

Umezawa, K., Yoshida, M., Kamiya, M., Yamasoba, T., & Urano, Y. (2017). Rational design of reversible fluorescent probes for live-cell imaging and quantification of fast glutathione dynamics. Nature Chemistry, 9(3), 279–286.

Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., et al. (2016). Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nature Nanotechnology, 11(6), 533–538.

Iwasaki, S., & Yamasoba, T. (2014). Dizziness and imbalance in the elderly: Age-related decline in the vestibular system. Aging and Disease, 6(1), 38–47.

Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., et al. (2009). Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences, 106(46), 19432–19437.

Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Published on by Neuroscientists

Dr. Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | National and Kapodistrian University of Athens | Greece

Dr. Efstratios-Stylianos Pyrgelis is a distinguished Neurologist and Ph.D. scholar affiliated with the National and Kapodistrian University of Athens. His extensive research contributions span neurochemistry, neuroimaging, and normal pressure hydrocephalus, reflecting a deep commitment to advancing clinical neuroscience. With over 40 published articles in SCI- and Scopus-indexed journals and authorship of 4 international medical books, Dr. Pyrgelis has established a strong academic footprint. His scholarly influence is demonstrated by a total of 510 citations, an h-index of 11, and an i10-index of 12, as recorded on Google Scholar. As a Review Editor for Frontiers in Neurology and Guest Editor for Diagnostics, he plays a pivotal role in shaping contemporary neurological research. He collaborates with the CNS Alliance Research Group and maintains professional memberships with the Greek Neurologic Society and the Medical Association of Chios. Beyond academia, he has contributed to consultancy projects linking research with clinical applications. Through his innovative work and international collaborations, Dr. Pyrgelis continues to contribute significantly to the understanding and treatment of neurological disorders, reinforcing his reputation as one of Greece’s leading researchers in the field of neuroscience.

Profiles: Orcid | Research Gate

Featured Publications

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Stefanis, L., & Kapaki, E. (2024). In vivo prevalence of beta-amyloid pathology and Alzheimer’s disease co-pathology in idiopathic normal-pressure hydrocephalus—Association with neuropsychological features. Biomedicines, 12(8), 1898.

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Papaioannou, M., Stefanis, L., & Kapaki, E. (2023). Alzheimer’s disease CSF biomarkers as possible indicators of tap-test response in idiopathic normal pressure hydrocephalus. Brain Sciences, 13(11), 1593.

Angelopoulou, E., Pyrgelis, E.-S., Ahire, C., Suman, P., Mishra, A., & Piperi, C. (2023). Functional implications of protein arginine methyltransferases (PRMTs) in neurodegenerative diseases. Biology, 12(9), 1257.

Pyrgelis, E.-S., Velonakis, G., Papageorgiou, S. G., Stefanis, L., Kapaki, E., & Constantinides, V. C. (2023). Imaging markers for normal pressure hydrocephalus: An overview. Biomedicines, 11(5), 1265.

Constantinides, V. C., Paraskevas, G. P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., & Kapaki, E. (2023). CSF Aβ42 and Aβ42/Aβ40 ratio in Alzheimer’s disease and frontotemporal dementias. Diagnostics, 13(4), 783.

Constantinides, V. C., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Ghika, A., Koros, C., Liakakis, G., Papageorgiou, S., Stefanis, L., Paraskevas, G. P., et al. (2023). Application of the AT(N) and other CSF classification systems in behavioral variant frontotemporal dementia. Diagnostics, 13(3), 332.

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022). Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: An update on preclinical and clinical evidence. Molecules, 27(23), 8448.

Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil |  National Research Centre | Egypt

Dr. Wagdy Khalil is a Professor of Animal Genetics specializing in Molecular Genetics at the Cell Biology Department, National Research Centre, Egypt. His research focuses on genetic and molecular mechanisms underlying animal reproduction, gene expression, and environmental genotoxicity. He has significantly contributed to the understanding of oocyte maturation, preovulatory hormonal regulation, and molecular responses to toxins, nanoparticles, and natural therapeutic agents. Dr. Khalil’s work integrates molecular biology, biotechnology, and animal genetics to explore the genetic basis of fertility, mutagenicity, and disease resistance. He has published 161 scientific papers in peer-reviewed journals indexed in Scopus, reflecting his consistent research productivity and international collaboration. His studies have advanced knowledge in fields such as reproductive biology, toxicogenomics, molecular diagnostics, and genetic engineering. Dr. Khalil’s impactful research has earned him 2,055 citations from 1,801 documents, demonstrating wide recognition within the scientific community. With an h-index of 27, his work continues to influence emerging research in molecular genetics and biotechnology, bridging fundamental discoveries with applied biomedical and agricultural innovations.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

  • Antiarthritic activities of berberine in a rat model of gouty arthritis. (2025). Scientific Reports.

  • Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. (2025). Scientific Reports.

  • Comparative study of pyridine and pyrimidine derivatives as promising anti-inflammatory agents: Design, synthesis, and LPS-induced RAW 264.7 macrophages. (2025). Drug Development Research.

  • Expression of growth factors in buffalo ovarian tissue across different follicular developmental stages. (2025). Archives of Gynecology and Obstetrics.

  • Estrus, preovulatory LH surge and oocyte maturation in Goettingen miniature pigs (Sus scrofa domesticus). (2025). Theriogenology.

  • Targeting apoptotic pathways in cancer: Design, synthesis, and molecular docking studies of 1,3,5-trisubstituted-1H-pyrazole derivatives with Bcl-2 inhibition and DNA damage potential. (2025). RSC Advances.

  • Assessment of the gold nanoparticles biosynthesized using Casuarina equisetifolia bark extract against the ethion-induced hepato- and neurotoxicity in rats. (2025). Journal of Genetic Engineering and Biotechnology.

  • In vitro and in vivo antidiabetic evaluation of new coumarin and chromone derivatives: Design, synthesis, and molecular modeling. (2025). Bioorganic Chemistry.

  • Potential therapeutic effects of interleukin-1 receptor type 1 antagonist and the ethyl acetate fraction of Murraya exotica leaves against κ-carrageenan-induced vein thrombosis in rats. (2025). Phytomedicine Plus.

  • The ability of stressor factors of environmental pollution to induce ROS and 8-OHdG mediated apoptosis in fish species of Suez Gulf, Red Sea. (2025). Egyptian Journal of Chemistry.

Li-Ru Zhao | Neurogenetics | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Li-Ru Zhao | Neurogenetics | Best Researcher Award

Dr. LR Zhao is a distinguished neuroscientist and professor at the State University of New York Upstate Medical University, with appointments in the Departments of Neurosurgery and Neuroscience & Physiology. He received his M.D. from Hebei Medical College and completed his Ph.D. at Lund University, focusing on neural stem cells, brain plasticity, and neurobiology. His postdoctoral work at the University of Minnesota explored the role of bone marrow stem cells in brain repair. Dr. Zhao’s research career spans multiple institutions, including Northwestern University and Louisiana State University Health Sciences Center, where he progressed from Research Assistant Professor to Associate Professor. His work primarily investigates mechanisms underlying brain repair and regeneration, with emphasis on traumatic brain injury, enriched environment interventions, and neurodegenerative diseases such as Alzheimer’s and CADASIL. He has successfully secured multiple NIH-funded grants, including R01 and R56 awards, totaling several million dollars, and has mentored numerous medical students through summer and research fellowship programs. Dr. Zhao has published 66 peer-reviewed documents, which have been cited 3,238 times by 2,814 documents, yielding an h-index of 27. His contributions have advanced understanding of hematopoietic growth factors in neurorepair, SCF+G-CSF-mediated recovery in chronic TBI, and the cellular mechanisms regulating neurodegeneration and regeneration, establishing him as a leader in translational neuroscience research.

Profiles: Scopus | Linked In

Featured Publications

  • Author(s). (2024). Research guideline recommendations for research on stem cells, human embryos, and gene editing.

  • Author(s). (2024). Hematopoietic growth factors regulate the entry of monocytes into the adult brain via chemokine receptor CCR5. International Journal of Molecular Sciences.

  • Author(s). (2024). Single-cell RNA sequencing reveals immunomodulatory effects of stem cell factor and granulocyte colony-stimulating factor treatment in the brains of aged APP/PS1 mice. Biomolecules.

  • Author(s). (2023). Stem cell factor and granulocyte colony-stimulating factor promote remyelination in the chronic phase of severe traumatic brain injury. Cells.

  • Author(s). (2021). SCF + G-CSF treatment in the chronic phase of severe TBI enhances axonal sprouting in the spinal cord and synaptic pruning in the hippocampus. Acta Neuropathologica Communications.